Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Head & Neck Oncology
Published in: Head & Neck Oncology 1/2009

Open Access 01-12-2009 | Review

Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer

Authors: Maarten AM Wildeman, Heike J Nyst, Baris Karakullukcu, Bing I Tan

Published in: Head & Neck Oncology | Issue 1/2009

Login to get access

Abstract

To determine the efficacy of Photodynamic therapy of patients with recurrent Nasopharyngeal Carcinoma we reviewed all available literature.
Since the treatment options for recurrent or persistent Nasopharyngeal Carcinoma are limited, the survival rates poor and the complications severe; there is definitely a place for alternative treatment modalities with more efficacy and less morbidity. Photodynamic therapy (PDT) has the potential to be a very effective local treatment modality for recurrent or persistent nasopharyngeal cancer, without the severe side effects seen with re-irradiation. This review shows all reported results of Photodynamic therapy in the treatment for Nasopharyngeal Carcinoma.
Appendix
Available only for authorised users
Literature
1.
Devi BC, Pisani P, Tang TS, Parkin DM: High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev. 2004, 13: 482-486.PubMed
2.
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed
3.
Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, Tung SY, Thaw M, Ho JH: Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992, 23: 261-270. 10.1016/0360-3016(92)90740-9.CrossRefPubMed
4.
Moench HC, Phillips TL: Carcinoma of the nasopharynx. Review of 146 patients with emphasis on radiation dose and time factors. Am J Surg. 1972, 124: 515-518. 10.1016/0002-9610(72)90077-3.CrossRefPubMed
5.
Chien CR, Chen SW, Hsieh CY, Liang JA, Yang SN, Huang CY, Lin FJ: Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in Taiwan. Jpn J Clin Oncol. 2001, 31: 363-369. 10.1093/jjco/hye087.CrossRefPubMed
6.
Kajanti MJ, Mantyla MJ: Carcinoma of the nasopharynx. A retrospective analysis of treatment results in 125 patients. Acta Oncol. 1990, 29: 611-614. 10.3109/02841869009090061.CrossRefPubMed
7.
Law SC, Lam WK, Ng MF, Au SK, Mak WT, Lau WH: Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage. Int J Radiat Oncol Biol Phys. 2002, 54: 1095-1113. 10.1016/S0360-3016(02)03009-2.CrossRefPubMed
8.
Kwong DL, Wei WI, Cheng AC, Choy DT, Lo AT, Wu PM, Sham JS: Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer. 2001, 91: 1105-1113. 10.1002/1097-0142(20010315)91:6<1105::AID-CNCR1106>3.0.CO;2-Z.CrossRefPubMed
9.
Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, SK O: Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 48: 1331-1338. 10.1016/S0360-3016(00)00776-8.CrossRefPubMed
10.
Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, SK O: Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 47: 405-412. 10.1016/S0360-3016(00)00463-6.CrossRefPubMed
11.
Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO: How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?. Int J Radiat Oncol Biol Phys. 1998, 40: 897-913. 10.1016/S0360-3016(97)00854-7.CrossRefPubMed
12.
Lee AW, Foo W, Law SC, Poon YF, Sze WM, SK O, Tung SY, Chappell R, Lau WH, Ho JH: Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys. 1999, 44: 149-156. 10.1016/S0360-3016(98)00524-0.CrossRefPubMed
13.
Hwang JM, Fu KK, Phillips TL: Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1998, 41: 1099-1111. 10.1016/S0360-3016(98)00164-3.CrossRefPubMed
14.
Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH: Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys. 2003, 56: 177-183. 10.1016/S0360-3016(03)00074-9.CrossRefPubMed
15.
Al Sarraf M, Reddy MS: Nasopharyngeal carcinoma. Curr Treat Options Oncol. 2002, 3: 21-32. 10.1007/s11864-002-0038-8.CrossRefPubMed
16.
Pryzant RM, Wendt CD, Delclos L, Peters LJ: Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys. 1992, 22: 941-947. 10.1016/0360-3016(92)90792-G.CrossRefPubMed
17.
Lee AW, Law SC, Foo W, Poon YF, Cheung FK, Chan DK, Tung SY, Thaw M, Ho JH: Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993, 26: 773-782. 10.1016/0360-3016(93)90491-D.CrossRefPubMed
18.
Lee AW, Foo W, Law SC, Peters LJ, Poon YF, Chappell R, Sze WM, Tung SY, Lau WH, Ho JH: Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000, 46: 865-872. 10.1016/S0360-3016(99)00512-X.CrossRefPubMed
19.
Sun ZQ: [Photodynamic therapy of nasopharyngeal carcinoma by argon or dye laser--an analysis of 137 cases]. Zhonghua Zhong Liu Za Zhi. 1992, 14: 290-292.PubMed
20.
Kulapaditharom B, Boonkitticharoen V: Photodynamic therapy in the treatment of head and neck cancers: a two-year experience. J Med Assoc Thai. 1996, 79: 229-235.PubMed
21.
Kulapaditharom B, Boonkitticharoen V: Photodynamic therapy in management of head and neck cancers and precancerous lesions. J Med Assoc Thai. 2000, 83: 249-258.PubMed
22.
Tong MC, van Hasselt CA, Woo JK: Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 1996, 253: 189-192. 10.1007/BF00615121.CrossRefPubMed
23.
Lofgren LA, Hallgren S, Nilsson E, Westerborn A, Nilsson C, Reizenstein J: Photodynamic therapy for recurrent nasopharyngeal cancer. Arch Otolaryngol Head Neck Surg. 1995, 121: 997-1002.CrossRefPubMed
24.
Yow CM, Chen JY, Mak NK, Cheung NH, Leung AW: Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. Cancer Lett. 2000, 157: 123-131. 10.1016/S0304-3835(00)00453-5.CrossRefPubMed
25.
Yow CM, Mak NK, Szeto S, Chen JY, Lee YL, Cheung NH, Huang DP, Leung AW: Photocytotoxic and DNA damaging effect of temoporfin (mTHPC) and merocyanine 540 (MC540) on nasopharyngeal carcinoma cell. Toxicol Lett. 2000, 115: 53-61. 10.1016/S0378-4274(00)00174-0.CrossRefPubMed
26.
Nyst HJ, van Veen RL, Tan IB, Peters R, Spaniol S, Robinson DJ, Stewart FA, Levendag PC, Sterenborg HJ: Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments. Lasers Surg Med. 2007, 39: 647-653. 10.1002/lsm.20536.CrossRefPubMed
27.
van Veen RL, Nyst H, Rai Indrasari S, Adham Yudharto M, Robinson DJ, Tan IB, Meewis C, Peters R, Spaniol S, Stewart FA, et al: In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator. J Biomed Opt. 2006, 11: 041107-10.1117/1.2338009.CrossRefPubMed
28.
D'Cruz AK, Robinson MH, Biel MA: mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004, 26: 232-240. 10.1002/hed.10372.CrossRefPubMed
29.
Korbelik M, Sun J, Cecic I, Serrano K: Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci. 2004, 3: 812-816. 10.1039/b315663j.CrossRefPubMed
30.
Olivo M, Du HY, Bay BH: Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. Curr Clin Pharmacol. 2006, 1: 217-222. 10.2174/157488406778249370.CrossRefPubMed
31.
Koon H, Leung AW, Yue KK, Mak NK: Photodynamic effect of curcumin on NPC/CNE2 cells. J Environ Pathol Toxicol Oncol. 2006, 25: 205-215.CrossRefPubMed
32.
Xu CS, Leung AW: Photodynamic effects of pyropheophorbide-a methyl ester in nasopharyngeal carcinoma cells. Med Sci Monit. 2006, 12: BR257-BR262.PubMed
33.
Mak NK, Kok TW, Wong RN, Lam SW, Lau YK, Leung WN, Cheung NH, Huang DP, Yeung LL, Chang CK: Photodynamic activities of sulfonamide derivatives of porphycene on nasopharyngeal carcinoma cells. J Biomed Sci. 2003, 10: 418-429. 10.1007/BF02256433.CrossRefPubMed
34.
Betz CS, Lai JP, Xiang W, Janda P, Heinrich P, Stepp H, Baumgartner R, Leunig A: In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci. 2002, 1: 315-319. 10.1039/b109817a.CrossRefPubMed
35.
Bae SM, Kim YW, Kwak SY, Kim YW, Ro DY, Shin JC, Park CH, Han SJ, Oh CH, Kim CK, et al: Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells. Cancer Sci. 2007, 98: 747-752. 10.1111/j.1349-7006.2007.00447.x.CrossRefPubMed
Metadata
Title
Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer
Authors
Maarten AM Wildeman
Heike J Nyst
Baris Karakullukcu
Bing I Tan
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2009
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-1-40

Other articles of this Issue 1/2009

Head & Neck Oncology 1/2009 Go to the issue

Commentary

Getting the basics right-staging in head and neck cancer

Commentary

Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment

Research

Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years

Case report

Basal cell adenocarcinoma of a hard palate minor salivary gland: case report and review of the literature

Research

Adenoid cystic carcinoma of the tongue – clinicopathological study and survival analysis

Review

Refeeding syndrome – awareness, prevention and management
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits